[SCHEDULE 13G/A] TKO Group Holdings, Inc. SEC Filing

Rhea-AI Filing Summary

Teva Pharmaceutical Industries Ltd. (TEVA) – Form 144 notice

An unidentified affiliate has filed to sell up to 6,053 ordinary shares via Citigroup Global Markets on the NYSE, with an aggregate market value of roughly US$91,748. The shares were acquired as a restricted-share-unit award on 01 Aug 2022 and satisfy Rule 144’s two-year holding-period requirement. The proposed trade window opens on 01 Aug 2025.

Teva has about 1.147 billion shares outstanding, so the sale would equal <0.001 % of the float—far below any level that could affect liquidity, ownership concentration or voting control. A Form 144 is only a notice; the transaction may not ultimately occur and no pricing details were provided beyond the broker of record.

Positive

• None.

Negative

• Insider selling signal: Even though the volume is trivial, any planned insider sale can be perceived negatively by some investors tracking management sentiment.

Insights

Securities Analyst

TL;DR: De minimis insider sale; neutral for valuation.

The 6,053-share sale equates to under US$0.1 m against Teva’s multi-billion-dollar market cap and >1 billion share count. Such a small disposition will not affect liquidity or EPS and does not imply strategic change. Insider intent might garner minor attention, but the transaction volume is immaterial. Overall, I view the filing as routine administrative disclosure with no discernible impact on the investment thesis.

Corporate Governance Expert

TL;DR: Routine Rule 144 compliance; governance risk unchanged.

The filer certifies no undisclosed adverse information, satisfying Rule 144 and 10b5-1 safeguards. Absence of recent clustered insider selling or large volume keeps governance risk unchanged. I classify the event as not impactful to shareholders’ governance considerations.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

TKO Group Holdings, Inc.

(Name of Issuer)

Class A Common Stock, par value $0.00001

(Title of Class of Securities)

87256C101

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 87256C101

1

Names of Reporting Persons

Vincent K. McMahon

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 6,442,325.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 6,442,325.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

6,442,325.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.88 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: Calculated assuming 81,747,465 shares of Class A Common Stock outstanding as of April 30, 2025, as reported on the Issuer's Form 10-Q filed May 8, 2025.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: TKO Group Holdings, Inc.
(b)	Address of issuer's principal executive offices: 200 Fifth Ave., 7th Floor, New York, NY 10010
Item 2.
(a)	Name of person filing: This statement is filed by the Vincent K. McMahon, referred to herein as the "Reporting Person."
(b)	Address or principal business office or, if none, residence: c/o McMahon Ventures 1055 Washington Blvd Stamford, CT 06901
(c)	Citizenship: See response to Item 4 on the cover page.
(d)	Title of class of securities: Class A Common Stock, par value $0.00001
(e)	CUSIP No.: 87256C101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See response to Item 9 on the cover page.
(b)	Percent of class: See response to Item 11 on the cover page.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See response to Item 5 on the cover page.
	(ii) Shared power to vote or to direct the vote: See response to Item 6 on the cover page.
	(iii) Sole power to dispose or to direct the disposition of: See response to Item 7 on the cover page.
	(iv) Shared power to dispose or to direct the disposition of: See response to Item 8 on the cover page.
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Vincent K. McMahon

Signature:	/s/ Vincent K. McMahon
Name/Title:	Vincent K. McMahon
Date:	08/01/2025

FAQ

What did the TEVA Form 144 disclose?

It disclosed an insider's intent to sell 6,053 ordinary shares valued at about US$91,748.

When can the TEVA shares be sold under Rule 144?

The filing lists an approximate sale date of 01 Aug 2025.

How significant is the planned sale relative to TEVA’s float?

With 1.147 billion shares outstanding, the sale equals <0.001 % of total shares.

Where will the sale take place and who is the broker?

The shares are slated for sale on the NYSE through Citigroup Global Markets.

Were the shares purchased or awarded?

They were acquired as a restricted share-unit award on 01 Aug 2022.

Does the filing guarantee the transaction will occur?

No. Form 144 is only a notice; the insider may decide not to execute the sale.